国際オンライン医療評議会 (IOMC) | 医学研究

GET THE APP

抽象化/インデックス化

Jゲート開いて、ゲノミクス、 グーグル スカラー、ISA (インド科学抄録)、CAS (化学抄録サービス)、CABI (英国)、インデックスコペルニクス、ヒナリ、エブスコ、ウルリッヒの定期編集物ディレクトリ、植物農薬、雑草抄録、 アグバイオテックネット、獣医師リソース、作物生理学抄録、アグロフォレストリー抄録、蠕虫学抄録トラクト、観賞用園芸、植物遺伝資源の概要、豚のニュースと情報、酪農科学の概要、農業経済データベース、寄生虫学データベース、CAB概要、動物記録、収穫後のニュースと情報、栄養と食品科学のデータベース、有機データベース、グローバル、ヘルス、ABC化学、サイエンスセントラル、シマゴなど、さらに多くのデータが処理中です。

短いコミュニケーション

The Human Element of Breast Cancer: Insights from Pakistan

Maggi Banning

Pakistan is a developing country that has the highest rate of breast cancer in Asia . This is reflected in the age standardised ratio is 69.1 per 100,000 averaged from 1998 -200..もっと見る»

研究論文

Discontinuation of Tnf-Alfa Inhibitors in Rheumatoid Arthritis Remission

Izabela Domyslawska, Gindzienska-Sieskiewicz Ewa, Chrostowski Tomek, Klimiuk A. Piotr and Sierakowski Stanislaw

Objectives: The process of medication for patients with Rheumatoid arthritis until the moment of remission is well-described. However, there is a lack of detail..もっと見る»

視点

The Job of Course Commonality in Rush Hour Gridlock Members' Way of Behaving and Transport Brain Science Research

Alex Smith

Investigations of how transport conduct (e.g., driving, cycling, and strolling) is impacted by training and commonality are not ordinary, notwithstanding the way that amount of ..もっと見る»

研究論文

Exploring Older Peoples’ Perceptions of their Pathways through Healthcare: an Embedded MultiCase Study

Sue M Ashby, Roger Beech , Sue Read and Sian E Maslin-Prothero

Background: A global trend of shifting healthcare to the community is taking place to meet the needs of an increasing ageing population. Resulting care pathways..もっと見る»

編集後記

Medication in Rheumatoid Arthritis

Hiroshi Kawaguchi

Drugs type the mainstay of medical aid in rheumatism (RA). 5 main categories of medicine are presently used: analgesics, non-steroidal anti-inflammatories (NSAIDs), glucocortico..もっと見る»

短いコミュニケーション

Benefit-Risk of Immunomodulators in Multiple Sclerosis. Alemtuzumab and Next?

Francois Curtin

End of December 2013, alemtuzumab, a monoclonal antibody for multiple sclerosis (MS) with an immunomodulator
action targeting CD52 receptors and inducing decrease counts ..もっと見る»